N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial

BACKGROUND: The aim was to test the primary hypothesis that in patients suffering from shock, treatment with N-acetylcysteine (NAC) plus deferoxamine (DFX) decreases the incidence of acute kidney injury (AKI). METHODS: A double-blind, randomized, placebo-controlled trial was conducted in a general i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraga, Cassiana Mazon, Tomasi, Cristiane Damiani, Damasio, Danusa de Castro, Vuolo, Francieli, Ritter, Cristiane, Dal-Pizzol, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066295/
https://www.ncbi.nlm.nih.gov/pubmed/27745551
http://dx.doi.org/10.1186/s13054-016-1504-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066295/
https://www.ncbi.nlm.nih.gov/pubmed/27745551
http://dx.doi.org/10.1186/s13054-016-1504-1

Ejemplares similares